<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32762702</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>02</Day></DateCompleted><DateRevised><Year>2021</Year><Month>07</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1742-2094</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Aug</Month><Day>06</Day></PubDate></JournalIssue><Title>Journal of neuroinflammation</Title><ISOAbbreviation>J Neuroinflammation</ISOAbbreviation></Journal><ArticleTitle>Chitotriosidase, a biomarker of amyotrophic lateral sclerosis, accentuates neurodegeneration in spinal motor neurons through neuroinflammation.</ArticleTitle><Pagination><StartPage>232</StartPage><MedlinePgn>232</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">232</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12974-020-01909-y</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Cerebrospinal fluid from amyotrophic lateral sclerosis patients (ALS-CSF) induces neurodegenerative changes in motor neurons and gliosis in sporadic ALS models. Search for identification of toxic factor(s) in CSF revealed an enhancement in the level and enzyme activity of chitotriosidase (CHIT-1). Here, we have investigated its upregulation in a large cohort of samples and more importantly its role in ALS pathogenesis in a rat model.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">CHIT-1 level in CSF samples from ALS (n = 158), non-ALS (n = 12) and normal (n = 48) subjects were measured using ELISA. Enzyme activity was also assessed (ALS, n = 56; non-ALS, n = 10 and normal-CSF, n = 45). Recombinant CHIT-1 was intrathecally injected into Wistar rat neonates. Lumbar spinal cord sections were stained for Iba1, glial fibrillary acidic protein and choline acetyl transferase to identify microglia, astrocytes and motor neurons respectively after 48&#x2009;h of injection. Levels of tumour necrosis factor-&#x3b1; and interleukin-6 were measured by ELISA.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="RESULTS">CHIT-1 level in ALS-CSF samples was increased by 20-fold and it can distinguish ALS patients with a sensitivity of 87% and specificity of 83.3% at a cut&#xa0;off level of 1405.43&#x2009;pg/ml. Enzyme activity of CHIT-1 was also 15-fold higher in ALS-CSF and has a sensitivity of 80.4% and specificity of 80% at cut off value of 0.1077989&#x2009;&#x3bc;mol/&#x3bc;l/min. Combining CHIT-1 level and activity together gave a positive predictive value of 97.78% and negative predictive value of 100%. Administration of CHIT-1 increased microglial numbers and astrogliosis in the ventral horn with a concomitant increase in the levels of pro-inflammatory cytokines. Amoeboid-shaped microglial and astroglial cells were also present around the central canal. CHIT-1 administration also resulted in the reduction of motor neurons.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">CHIT-1, an early diagnostic biomarker of sporadic ALS, activates glia priming them to attain a toxic phenotype resulting in neuroinflammation leading to motor neuronal death.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Varghese</LastName><ForeName>Anu Mary</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Neurophysiology, National Institute of Mental Health and Neuro Sciences, Hosur Road, Bengaluru, 560 029, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghosh</LastName><ForeName>Mausam</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurophysiology, National Institute of Mental Health and Neuro Sciences, Hosur Road, Bengaluru, 560 029, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhagat</LastName><ForeName>Savita Kumari</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Department of Neurophysiology, National Institute of Mental Health and Neuro Sciences, Hosur Road, Bengaluru, 560 029, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vijayalakshmi</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurophysiology, National Institute of Mental Health and Neuro Sciences, Hosur Road, Bengaluru, 560 029, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Preethish-Kumar</LastName><ForeName>Veeramani</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Clinical Neuroscience, National Institute of Mental Health and Neuro Sciences, Hosur Road, Bengaluru, 560 029, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vengalil</LastName><ForeName>Seena</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, National Institute of Mental Health and Neuro Sciences, Hosur Road, Bengaluru, 560 029, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chevula</LastName><ForeName>Pradeep-Chandra-Reddy</ForeName><Initials>PC</Initials><AffiliationInfo><Affiliation>Department of Neurophysiology, National Institute of Mental Health and Neuro Sciences, Hosur Road, Bengaluru, 560 029, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nashi</LastName><ForeName>Saraswati</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, National Institute of Mental Health and Neuro Sciences, Hosur Road, Bengaluru, 560 029, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Polavarapu</LastName><ForeName>Kiran</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, National Institute of Mental Health and Neuro Sciences, Hosur Road, Bengaluru, 560 029, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharma</LastName><ForeName>Meenakshi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Non Communicable Disease, Indian Council of Medical Research, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dhaliwal</LastName><ForeName>Rupinder Singh</ForeName><Initials>RS</Initials><AffiliationInfo><Affiliation>Division of Non Communicable Disease, Indian Council of Medical Research, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Philip</LastName><ForeName>Mariamma</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, National Institute of Mental Health and Neuro Sciences, Hosur Road, Bengaluru, 560 029, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nalini</LastName><ForeName>Atchayaram</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, National Institute of Mental Health and Neuro Sciences, Hosur Road, Bengaluru, 560 029, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alladi</LastName><ForeName>Phalguni Anand</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Department of Clinical Pharmacology &amp; Neurotoxicology, National Institute of Mental Health and Neuro Sciences, Hosur Road, Bengaluru, 560 029, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sathyaprabha</LastName><ForeName>Talakad N</ForeName><Initials>TN</Initials><AffiliationInfo><Affiliation>Department of Neurophysiology, National Institute of Mental Health and Neuro Sciences, Hosur Road, Bengaluru, 560 029, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raju</LastName><ForeName>Trichur R</ForeName><Initials>TR</Initials><Identifier Source="ORCID">0000-0002-7742-4050</Identifier><AffiliationInfo><Affiliation>Department of Neurophysiology, National Institute of Mental Health and Neuro Sciences, Hosur Road, Bengaluru, 560 029, India. trraju.nimhans@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>No.5/4-5/128/Neuro/CAR/2013-NCD-I</GrantID><Agency>Indian Council of Medical Research</Agency><Country/></Grant><Grant><GrantID>BT/PR/4054/Med/30/349/2010</GrantID><Agency>Department of Biotechnology, Govt. of India</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>08</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Neuroinflammation</MedlineTA><NlmUniqueID>101222974</NlmUniqueID><ISSNLinking>1742-2094</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.1.-</RegistryNumber><NameOfSubstance UI="D006596">Hexosaminidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.1.-</RegistryNumber><NameOfSubstance UI="C086400">chitotriosidase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004660" MajorTopicYN="N">Encephalitis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006596" MajorTopicYN="N">Hexosaminidases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017628" MajorTopicYN="N">Microglia</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009410" MajorTopicYN="N">Nerve Degeneration</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017208" MajorTopicYN="N">Rats, Wistar</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Biomarker</Keyword><Keyword MajorTopicYN="N">Chitotriosidase</Keyword><Keyword MajorTopicYN="N">Glia</Keyword><Keyword MajorTopicYN="N">Neurodegeneration</Keyword><Keyword MajorTopicYN="N">Neuroinflammation</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>1</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>7</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>8</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32762702</ArticleId><ArticleId IdType="pmc">PMC7412641</ArticleId><ArticleId IdType="doi">10.1186/s12974-020-01909-y</ArticleId><ArticleId IdType="pii">10.1186/s12974-020-01909-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Boillee S, Vande Velde C, Cleveland DW. ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron. 2006;52:39&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pubmed">17015226</ArticleId></ArticleIdList></Reference><Reference><Citation>Farnikova K, Kanovsky P, Nestrasil I, Otruba P. Coexistence of parkinsonism, dementia and upper motor neuron syndrome in four Czech patients. J Neurol Sci. 2010;296:47&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">20619856</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilbert RM, Fahn S, Mitsumoto H, Rowland LP. Parkinsonism and motor neuron diseases: twenty-seven patients with diverse overlap syndromes. Mov Disord. 2010;25:1868&#x2013;1875.</Citation><ArticleIdList><ArticleId IdType="pubmed">20669307</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilieva H, Polymenidou M, Cleveland DW. Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J Cell Biol. 2009;187:761&#x2013;772.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2806318</ArticleId><ArticleId IdType="pubmed">19951898</ArticleId></ArticleIdList></Reference><Reference><Citation>Varghese AM, Sharma A, Mishra P, Vijayalakshmi K, Harsha HC, Sathyaprabha TN, Bharath SM, Nalini A, Alladi PA, Raju TR. Chitotriosidase - a putative biomarker for sporadic amyotrophic lateral sclerosis. Clin Proteomics. 2013;10:19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4220794</ArticleId><ArticleId IdType="pubmed">24295388</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinacker P, Verde F, Fang L, Feneberg E, Oeckl P, Roeber S, Anderl-Straub S, Danek A, Diehl-Schmid J, Fassbender K, et al. Chitotriosidase (CHIT1) is increased in microglia and macrophages in spinal cord of amyotrophic lateral sclerosis and cerebrospinal fluid levels correlate with disease severity and progression. J Neurol Neurosurg Psychiatry. 2018;89:239&#x2013;247.</Citation><ArticleIdList><ArticleId IdType="pubmed">29142138</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies G, Henrissat B. Structures and mechanisms of glycosyl hydrolases. Structure. 1995;3:853&#x2013;859.</Citation><ArticleIdList><ArticleId IdType="pubmed">8535779</ArticleId></ArticleIdList></Reference><Reference><Citation>Kzhyshkowska J, Gratchev A, Goerdt S. Human chitinases and chitinase-like proteins as indicators for inflammation and cancer. Biomark Insights. 2007;2:128&#x2013;146.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2717817</ArticleId><ArticleId IdType="pubmed">19662198</ArticleId></ArticleIdList></Reference><Reference><Citation>Sotgiu S, Barone R, Arru G, Fois ML, Pugliatti M, Sanna A, Rosati G, Musumeci S. Intrathecal chitotriosidase and the outcome of multiple sclerosis. Mult Scler. 2006;12:551&#x2013;557.</Citation><ArticleIdList><ArticleId IdType="pubmed">17086899</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Rosa M, Dell'Ombra N, Zambito AM, Malaguarnera M, Nicoletti F, Malaguarnera L. Chitotriosidase and inflammatory mediator levels in Alzheimer&#x2019;s disease and cerebrovascular dementia. Eur J Neurosci. 2006;23:2648&#x2013;2656.</Citation><ArticleIdList><ArticleId IdType="pubmed">16817867</ArticleId></ArticleIdList></Reference><Reference><Citation>Elias JA, Homer RJ, Hamid Q, Lee CG. Chitinases and chitinase-like proteins in T(H)2 inflammation and asthma. J Allergy Clin Immunol. 2005;116:497&#x2013;500.</Citation><ArticleIdList><ArticleId IdType="pubmed">16159614</ArticleId></ArticleIdList></Reference><Reference><Citation>Orchard PJ, Lund T, Miller W, Rothman SM, Raymond G, Nascene D, Basso L, Cloyd J, Tolar J. Chitotriosidase as a biomarker of cerebral adrenoleukodystrophy. J Neuroinflammation. 2011;8:144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3236018</ArticleId><ArticleId IdType="pubmed">22014002</ArticleId></ArticleIdList></Reference><Reference><Citation>Verbeek MM, Notting EA, Faas B, Claessens-Linskens R, Jongen PJ. Increased cerebrospinal fluid chitotriosidase index in patients with multiple sclerosis. Acta Neurol Scand. 2010;121:309&#x2013;314.</Citation><ArticleIdList><ArticleId IdType="pubmed">19925532</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Chen Y, Wei Q, Ou R, Cao B, Zhao B, Shang HF. Assessment of a multiple biomarker panel for diagnosis of amyotrophic lateral sclerosis. BMC Neurol. 2016;16:173.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5024522</ArticleId><ArticleId IdType="pubmed">27634542</ArticleId></ArticleIdList></Reference><Reference><Citation>Correale J, Fiol M. Chitinase effects on immune cell response in neuromyelitis optica and multiple sclerosis. Mult Scler. 2011;17:521&#x2013;531.</Citation><ArticleIdList><ArticleId IdType="pubmed">21159721</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattsson N, Tabatabaei S, Johansson P, Hansson O, Andreasson U, Mansson JE, Johansson JO, Olsson B, Wallin A, Svensson J, et al. Cerebrospinal fluid microglial markers in Alzheimer&#x2019;s disease: elevated chitotriosidase activity but lack of diagnostic utility. Neuromolecular Med. 2011;13:151&#x2013;159.</Citation><ArticleIdList><ArticleId IdType="pubmed">21567187</ArticleId></ArticleIdList></Reference><Reference><Citation>Pagliardini V, Pagliardini S, Corrado L, Lucenti A, Panigati L, Bersano E, Servo S, Cantello R, D'Alfonso S, Mazzini L. Chitotriosidase and lysosomal enzymes as potential biomarkers of disease progression in amyotrophic lateral sclerosis: a survey clinic-based study. J Neurol Sci. 2015;348:245&#x2013;250.</Citation><ArticleIdList><ArticleId IdType="pubmed">25563799</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson AG, Gray E, Thezenas ML, Charles PD, Evetts S, Hu MT, Talbot K, Fischer R, Kessler BM, Turner MR. Cerebrospinal fluid macrophage biomarkers in amyotrophic lateral sclerosis. Ann Neurol. 2018;83:258&#x2013;268.</Citation><ArticleIdList><ArticleId IdType="pubmed">29331073</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293&#x2013;299.</Citation><ArticleIdList><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao MS, Devi MG, Nalini A, Shahani N, Raju TR. Neurofilament phosphorylation is increased in ventral horn neurons of neonatal rat spinal cord exposed to cerebrospinal fluid from patients with amyotrophic lateral sclerosis. Neurodegeneration. 1995;4:397&#x2013;401.</Citation><ArticleIdList><ArticleId IdType="pubmed">8846233</ArticleId></ArticleIdList></Reference><Reference><Citation>Shobha K, Alladi PA, Nalini A, Sathyaprabha TN, Raju TR. Exposure to CSF from sporadic amyotrophic lateral sclerosis patients induces morphological transformation of astroglia and enhances GFAP and S100beta expression. Neurosci Lett. 2010;473:56&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">20170712</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayalakshmi K, Alladi PA, Ghosh S, Prasanna VK, Sagar BC, Nalini A, Sathyaprabha TN, Raju TR. Evidence of endoplasmic reticular stress in the spinal motor neurons exposed to CSF from sporadic amyotrophic lateral sclerosis patients. Neurobiol Dis. 2011;41:695&#x2013;705.</Citation><ArticleIdList><ArticleId IdType="pubmed">21168498</ArticleId></ArticleIdList></Reference><Reference><Citation>Shobha K, Vijayalakshmi K, Alladi PA, Nalini A, Sathyaprabha TN, Raju TR. Altered in-vitro and in-vivo expression of glial glutamate transporter-1 following exposure to cerebrospinal fluid of amyotrophic lateral sclerosis patients. J Neurol Sci. 2007;254:9&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">17254611</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra PS, Boutej H, Soucy G, Bareil C, Kumar S, Picher-Martel V, Dupr&#xe9; N, Kriz J, Julien J-P. Transmission of ALS pathogenesis by the cerebrospinal fluid. Acta neuropathologica communications. 2020;8:1&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7206749</ArticleId><ArticleId IdType="pubmed">32381112</ArticleId></ArticleIdList></Reference><Reference><Citation>Castellani RJ, Perry G, Smith MA. The role of novel chitin-like polysaccharides in Alzheimer disease. Neurotox Res. 2007;12:269&#x2013;274.</Citation><ArticleIdList><ArticleId IdType="pubmed">18201954</ArticleId></ArticleIdList></Reference><Reference><Citation>Castellani RJ, Siedlak SL, Fortino AE, Perry G, Ghetti B, Smith MA. Chitin-like polysaccharides in Alzheimer&#x2019;s disease brains. Curr Alzheimer Res. 2005;2:419&#x2013;423.</Citation><ArticleIdList><ArticleId IdType="pubmed">16248847</ArticleId></ArticleIdList></Reference><Reference><Citation>Pradat PF, Bruneteau G, Gordon PH, Dupuis L, Bonnefont-Rousselot D, Simon D, Salachas F, Corcia P, Frochot V, Lacorte JM, et al. Impaired glucose tolerance in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2010;11:166&#x2013;171.</Citation><ArticleIdList><ArticleId IdType="pubmed">20184518</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawamata T, Akiyama H, Yamada T, McGeer PL. Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. Am J Pathol. 1992;140:691&#x2013;707.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1886170</ArticleId><ArticleId IdType="pubmed">1347673</ArticleId></ArticleIdList></Reference><Reference><Citation>Corcia P, Tauber C, Vercoullie J, Arlicot N, Prunier C, Praline J, Nicolas G, Venel Y, Hommet C, Baulieu JL, et al. Molecular imaging of microglial activation in amyotrophic lateral sclerosis. PLoS One. 2012;7:e52941.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3534121</ArticleId><ArticleId IdType="pubmed">23300829</ArticleId></ArticleIdList></Reference><Reference><Citation>Z&#xfc;rcher NR, Loggia ML, Lawson R, Chonde DB, Izquierdo-Garcia D, Yasek JE, Akeju O, Catana C, Rosen BR, Cudkowicz ME, et al. Increased in vivo glial activation in patients with amyotrophic lateral sclerosis: assessed with [(11)C]-PBR28. NeuroImage Clinical. 2015;7:409&#x2013;414.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4310932</ArticleId><ArticleId IdType="pubmed">25685708</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra PS, Vijayalakshmi K, Nalini A, Sathyaprabha TN, Kramer BW, Alladi PA, Raju TR. Etiogenic factors present in the cerebrospinal fluid from amyotrophic lateral sclerosis patients induce predominantly pro-inflammatory responses in microglia. J Neuroinflammation. 2017;14:251.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5732516</ArticleId><ArticleId IdType="pubmed">29246232</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapural M, Krizanac-Bengez L, Barnett G, Perl J, Masaryk T, Apollo D, Rasmussen P, Mayberg M, Janigro D. Serum S-100&#x3b2; as a possible marker of blood&#x2013;brain barrier disruption. Brain research. 2002;940:102&#x2013;104.</Citation><ArticleIdList><ArticleId IdType="pubmed">12020881</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchi N, Rasmussen P, Kapural M, Fazio V, Kight K, Mayberg MR, Kanner A, Ayumar B, Albensi B, Cavaglia M. Peripheral markers of brain damage and blood-brain barrier dysfunction. Restorative neurology and neuroscience. 2003;21:109&#x2013;121.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4066375</ArticleId><ArticleId IdType="pubmed">14530574</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahani N, Nalini A, Gourie-Devi M, Raju TR. Reactive astrogliosis in neonatal rat spinal cord after exposure to cerebrospinal fluid from patients with amyotrophic lateral sclerosis. Experimental Neurology. 1998;149:295&#x2013;298.</Citation><ArticleIdList><ArticleId IdType="pubmed">9454639</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaz-Amarilla P, Olivera-Bravo S, Trias E, Cragnolini A, Martinez-Palma L, Cassina P, Beckman J, Barbeito L. Phenotypically aberrant astrocytes that promote motoneuron damage in a model of inherited amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A. 2011;108:18126&#x2013;18131.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3207668</ArticleId><ArticleId IdType="pubmed">22010221</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlen M, Meletis K, Goritz C, Darsalia V, Evergren E, Tanigaki K, Amendola M, Barnabe-Heider F, Yeung MS, Naldini L, et al. Forebrain ependymal cells are Notch-dependent and generate neuroblasts and astrocytes after stroke. Nat Neurosci. 2009;12:259&#x2013;267.</Citation><ArticleIdList><ArticleId IdType="pubmed">19234458</ArticleId></ArticleIdList></Reference><Reference><Citation>Meletis K, Barnabe-Heider F, Carlen M, Evergren E, Tomilin N, Shupliakov O, Frisen J. Spinal cord injury reveals multilineage differentiation of ependymal cells. PLoS Biol. 2008;6:e182.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2475541</ArticleId><ArticleId IdType="pubmed">18651793</ArticleId></ArticleIdList></Reference><Reference><Citation>Beers DR, Henkel JS, Xiao Q, Zhao W, Wang J, Yen AA, Siklos L, McKercher SR, Appel SH. Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A. 2006;103:16021&#x2013;16026.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1613228</ArticleId><ArticleId IdType="pubmed">17043238</ArticleId></ArticleIdList></Reference><Reference><Citation>Haidet-Phillips AM, Hester ME, Miranda CJ, Meyer K, Braun L, Frakes A, Song S, Likhite S, Murtha MJ, Foust KD, et al. Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nat Biotechnol. 2011;29:824&#x2013;828.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3170425</ArticleId><ArticleId IdType="pubmed">21832997</ArticleId></ArticleIdList></Reference><Reference><Citation>Graber DJ, Hickey WF, Harris BT. Progressive changes in microglia and macrophages in spinal cord and peripheral nerve in the transgenic rat model of amyotrophic lateral sclerosis. J Neuroinflammation. 2010;7:8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2825214</ArticleId><ArticleId IdType="pubmed">20109233</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra PS, Dhull DK, Nalini A, Vijayalakshmi K, Sathyaprabha TN, Alladi PA, Raju TR. Astroglia acquires a toxic neuroinflammatory role in response to the cerebrospinal fluid from amyotrophic lateral sclerosis patients. J Neuroinflammation. 2016;13:212.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5006495</ArticleId><ArticleId IdType="pubmed">27578023</ArticleId></ArticleIdList></Reference><Reference><Citation>Drannik A, Martin J, Peterson R, Ma X, Jiang F, Turnbull J. Cerebrospinal fluid from patients with amyotrophic lateral sclerosis inhibits sonic hedgehog function. PLoS One. 2017;12:e0171668.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5295673</ArticleId><ArticleId IdType="pubmed">28170441</ArticleId></ArticleIdList></Reference><Reference><Citation>Ono S, Hu J, Shimizu N, Imai T, Nakagawa H. Increased interleukin-6 of skin and serum in amyotrophic lateral sclerosis. J Neurol Sci. 2001;187:27&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">11440741</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizwicki MT, Fiala M, Magpantay L, Aziz N, Sayre J, Liu G, Siani A, Chan D, Martinez-Maza O, Chattopadhyay M, La Cava A. Tocilizumab attenuates inflammation in ALS patients through inhibition of IL6 receptor signaling. Am J Neurodegener Dis. 2012;1:305&#x2013;315.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3560466</ArticleId><ArticleId IdType="pubmed">23383400</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsson B, Malmestrom C, Basun H, Annas P, Hoglund K, Lannfelt L, Andreasen N, Zetterberg H, Blennow K. Extreme stability of chitotriosidase in cerebrospinal fluid makes it a suitable marker for microglial activation in clinical trials. J Alzheimers Dis. 2012;32:273&#x2013;276.</Citation><ArticleIdList><ArticleId IdType="pubmed">22785399</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayalakshmi K, Alladi PA, Sathyaprabha TN, Subramaniam JR, Nalini A, Raju TR. Cerebrospinal fluid from sporadic amyotrophic lateral sclerosis patients induces degeneration of a cultured motor neuron cell line. Brain Research. 2009;1263:122&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pubmed">19368830</ArticleId></ArticleIdList></Reference><Reference><Citation>Sankaranarayani R, Nalini A, Rao Laxmi T, Raju TR. Altered neuronal activities in the motor cortex with impaired motor performance in adult rats observed after infusion of cerebrospinal fluid from amyotrophic lateral sclerosis patients. Behav Brain Res. 2010;206:109&#x2013;119.</Citation><ArticleIdList><ArticleId IdType="pubmed">19747511</ArticleId></ArticleIdList></Reference><Reference><Citation>Sankaranarayani R, Raghavan M, Nalini A, Laxmi TR, Raju TR. Reach task-associated excitatory overdrive of motor cortical neurons following infusion with ALS-CSF. J Neural Transm (Vienna) 2014;121:49&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">23900732</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasoanandrianina H, Grapperon AM, Taso M, Girard OM, Duhamel G, Guye M, Ranjeva JP, Attarian S, Verschueren A, Callot V. Region-specific impairment of the cervical spinal cord (SC) in amyotrophic lateral sclerosis: a preliminary study using SC templates and quantitative MRI (diffusion tensor imaging/inhomogeneous magnetization transfer). NMR Biomed. 2017;30(12):e3801.</Citation><ArticleIdList><ArticleId IdType="pubmed">28926131</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>